R&D & Funding
The UK leaving the EU will have an impact on some business’ R&D activities and funding. The following is official guidance from the Government relating to the life sciences industry, focusing on how to prepare for a no-deal outcome.
Please see the Regulation & IP page
UK regulations on access to genetic resources and the fair and equitable sharing of benefits arising from their utilisation (the Nagoya Protocol) that will continue to be operable after the UK leaves the EU